A TRIAL TO DETERMINE THE SAFETY AND ANTI-TUMOR ACTIVITY PROFILE OF THE COMBINATION OF CETUXIMAB AND CONCOMITANT CISPLATIN PLUS 5-FLUOROURACIL (5-FU) IN SUBJECTS WITH RECURRENT AND/OR METASTATIC SQUAMOUS CELL CARCINOMA IN HEAD AND NECK: